Just Published: "Amorfix Life Sciences Ltd. (AMF) - Product Pipeline Analysis, 2014 Update"
Amorfix Life Sciences Ltd. (Amorfix) is a development stage biopharmaceutical company. It focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting cancer and amyotrophic lateral sclerosis (ALS). The company developed two new technologies, namely, Epitope Protection and AMFIA for identifying...
View full press release